Skip to content

Adapsyn is a chemical bioinformatics company that discovers and develops novel bacterial metabolites for use as therapeutics

  Explore the Technology

We apply proprietary computational tools to bacterial metabolomic and genomic data in order to identify, isolate, and assay novel drug-like small molecules in high-throughput to expedite the search for medicines that will better protect us from a wide spectrum of diseases.